InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,182.00
(
0.62%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
83.03
(
-0.60%
)
Bitcoin
70,929.54
(
-0.73%
)
Post# of 134
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

whytestocks

Send PM Follow Ignore
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

whytestocks

Re: None

Wednesday, 06/19/2019 10:00:53 AM

Wednesday, June 19, 2019 10:00:53 AM

Post# of 134
News: $MLNT Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia

~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October 24, 2019 ~ MORRISTOWN, N.J., June 19, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, ...

Got this from https://marketwirenews.com/news-releases/melinta-therapeutics-announces-u-s-fda-acceptance-of-supplemental-new-drug-application-for-baxdela-xae-delafloxacin-for-the-treatment-of-community-acquired-bacterial-pneumonia-8380734.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up